BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27086851)

  • 1. SUMOylation of the KRAB zinc-finger transcription factor PARIS/ZNF746 regulates its transcriptional activity.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2016 May; 473(4):1261-1267. PubMed ID: 27086851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF4-mediated SUMO-targeted ubiquitination relieves PARIS/ZNF746-mediated transcriptional repression.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2020 May; 526(1):110-116. PubMed ID: 32197837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
    Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
    Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
    Gross M; Yang R; Top I; Gasper C; Shuai K
    Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
    Onishi S; Kataoka K
    J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
    Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1alpha: regulation by SUMOylation and oxidation.
    Zhong N; Xu J
    Hum Mol Genet; 2008 Nov; 17(21):3357-67. PubMed ID: 18689799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-specific protease SENP3 enhances MDM2-mediated ubiquitination of PARIS/ZNF746 in HeLa cells.
    Nishida T
    Biochem Biophys Res Commun; 2022 Jul; 615():150-156. PubMed ID: 35623300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARIS-DJ-1 Interaction Regulates Mitochondrial Functions in Cardiomyocytes, Which Is Critically Important in Cardiac Hypertrophy.
    Mukherjee D; Chander V; Bandyopadhyay A
    Mol Cell Biol; 2020 Dec; 41(1):. PubMed ID: 33077496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUF3669, a "domain of unknown function" within ZNF746 and ZNF777, oligomerizes and contributes to transcriptional repression.
    Al Chiblak M; Steinbeck F; Thiesen HJ; Lorenz P
    BMC Mol Cell Biol; 2019 Dec; 20(1):60. PubMed ID: 31856708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain.
    Mascle XH; Germain-Desprez D; Huynh P; Estephan P; Aubry M
    J Biol Chem; 2007 Apr; 282(14):10190-202. PubMed ID: 17298944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
    Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
    Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
    Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
    Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
    Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
    Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
    Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
    Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.